DarioHealth is a publicly traded company (Nasdaq: DRIO)
Delivering innovative digital health solutions to humans
DarioHealth Corp. is a leading global digital health company serving its users with dynamic mobile health solutions. In today’s day in age, knowledge of health and treatment is being democratized and we believe people deserve to know everything about their own health, and at the same time have the best tools to manage their treatment.
DarioHealth employs a revolutionary approach whereby harnessing big data, we have developed unique ways for people to analyze and personalize their chronic disease management. DarioHealth’s approach has taken the best of both worlds – the world of the wearable market, which is projected to reach $51.6B in just a few years, and the monitoring market that is climbing toward the $30B mark* – and flipped traditional health upside down. We are moving from periodic data to continuous data, from general treatment to personalized treatment, and from theory-driven solutions to adapted data & AI/ML technology. DarioHealth’s solutions span the full spectrum of disease monitoring, management, populations, and engagement.
What truly makes DarioHealth a remarkable investment opportunity is the fact that it has steadily grown from being a user-centric, direct-to-consumer company to a mature organization that is fully data-driven and able to provide a wide-range of managed care solutions. At the hub of it all is DarioHealth’s proprietary engagement platform, which has been painstakingly built by carefully monitoring and analyzing big data. Today, DarioHealth boasts phenomenal solutions and automated, full-suite services for the biggest players in the diabetes care management space.
With tens of thousands of active users worldwide and proven clinical outcomes, DarioHealth is a global digital therapeutics solution leader revolutionizing the way people manage their chronic conditions. Built for and around the user, Dario has created individualized solutions that combine best practices in digital technologies, analytics, hardware, and personal coaching that gently instructs, encourages, and inspires users… To self-manage their health day to day.
At Dario, the user always comes first. From designing the medical hardware and mobile applications to defining the communications and coaching, Dario’s goal is to create solutions that engage, inspire and motivate users to make Dario a part of their daily journey towards healthy living. Every user is different. And every day is different. When self-monitoring a chronic condition, having accurate, personal information available in real-time is critical for adapting to the fluctuations of daily life.
Who Is Dario For?
People who want to understand how their everyday life impacts their personal health, and what actions they can take to improve their health, how to better collaborate with healthcare providers and to live their life on their own terms.
Businesses looking to increase employee satisfaction, loyalty, and productivity with fewer health-related absences can take advantage of Dario’s services for employers.
Healthcare Providers wanting to boost patient compliance will find that Dario’s interactive services allow for greater monitoring capabilities, and the means to engage with patients to offer the right treatment at the right time.
Health Plans seeking better patient outcomes and lower costs will value Dario’s solutions that encourage patients to be more involved in managing their conditions, and proactively take preventative measures that reduce risk, emergency room visits, and preventable hospitalization.
Nothing in the contents transmitted on this board should be construed as an investment advisory, nor should it be used to make investment decisions. There is no express or implied solicitation to buy or sell securities. The author(s) may have positions in the stocks or financial relationships with the company or companies discussed and may trade in the stocks mentioned. Readers are advised to conduct their own due diligence prior to considering buying or selling any stock. All information should be considered for information purposes only. No stock exchange has approved or disapproved of the information here.